{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:38:51Z","timestamp":1793047131749,"version":"4.5.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Gain of function (GOF) mutations in <jats:italic toggle=\"yes\">PIK3CD<\/jats:italic> gene encoding PI3K p110\u03b4 were recently associated with a novel combined immune deficiency characterized by recurrent sinopulmonary infections, CD<jats:sub>4<\/jats:sub>\n                                 <jats:sup>+<\/jats:sup> lymphopenia, reduced class-switched memory B cells, lymphadenopathy, cytomegalovirus and\/or epstein-Barr virus (EBV) viremia, and EBV-related lymphoma. A subset of affected patients also had elevated serum IgM.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We report a patient who was diagnosed with systemic lupus erythematosus (SLE) at a young age and was recently found to carry heterozygous mutations in <jats:italic toggle=\"yes\">PIK3CD<\/jats:italic>. The patient not only presented with recurrent sinopulmonary infections, CD<jats:sub>4<\/jats:sub>\n                                 <jats:sup>+<\/jats:sup> lymphopenia, lymphadenopathy, EBV viremia, and elevated serum IgM, but also met classification criteria of SLE based on persistent proteinuria and hematuria, leukopenia and anemia, low level of serum complement, and positive autoantibody for antinuclear antibodies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Activated PI3K\u03b4 syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Oral prednisolone and hydroxychloroquine combined with mycophenolate mofetil was given to the patient. He was currently receiving intravenous immunoglobulin per month in association with hydroxychloroquine, low-dose prednisolone, and mycophenolate mofetil.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>At present, the level of complement restored to normal, hematuria and proteinuria disappeared, and liver function returned to normal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>SLE may be a novel phenotype of GOF mutation in <jats:italic toggle=\"yes\">PI3CKD<\/jats:italic> gene (GOF PIK3CD).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000015329","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T11:02:08Z","timestamp":1556794928000},"page":"e15329","source":"Crossref","is-referenced-by-count":22,"title":["A mutation in PIK3CD gene causing pediatric systemic lupus erythematosus"],"prefix":"10.1097","volume":"98","author":[{"given":"Guo-Min","family":"Li","sequence":"first","affiliation":[{"name":"Department of Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Mei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Zhen","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Bing","family":"Wu","sequence":"additional","affiliation":[{"name":"Medical Transformation Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yan","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Pathology, Children's Hospital of Fudan University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"(Pt 5)","key":"R1-20230914","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1242\/jcs.093773","article-title":"Classes of phosphoinositide 3-kinases at a glance","volume":"127","author":"Jean","year":"2014","journal-title":"J Cell Sci"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd4204","article-title":"PI3K and cancer: lessons, challenges and opportunities","volume":"13","author":"Fruman","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3389\/fimmu.2017.00747","article-title":"The selective phosphoinoside-3-kinase p110\u03b4 inhibitor IPI-3063 potently suppresses B cell survival, proliferation, and differentiation","volume":"8","author":"Chiu","year":"2017","journal-title":"Front Immunol"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1172\/JCI81746","article-title":"A human immunodeficiency caused by mutations in the PIK3R1 gene","volume":"125","author":"Deau","year":"2015","journal-title":"J Clin Invest"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/cei.12706","article-title":"Activating PI3K\u03b4 mutations in a cohort of 669 patients with primary immunodeficiency","volume":"183","author":"Elgizouli","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: a large patient cohort study","volume":"139","author":"Coulter","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fimmu.2018.00369","article-title":"Activated PI3 kinase delta syndrome: from genetics to therapy","volume":"9","author":"Michalovich","year":"2018","journal-title":"Front Immunol"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J Clin Immunol"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10875-017-0465-8","article-title":"The 2017 IUIS phenotypic classification for primary immunodeficiencies","volume":"38","author":"Bousfha","year":"2018","journal-title":"J Clin Immunol"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.autrev.2014.04.006","article-title":"Common variable immunodeficiency and autoimmunity \u2013 an inconvenient truth","volume":"13","author":"Xiao","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R11-20230914","first-page":"50","article-title":"Evaluation of humoral immune function in patients with chronic idiopathic thrombocytopenic purpura","volume":"12","author":"Rahiminejad","year":"2013","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"R12-20230914","first-page":"112","article-title":"Autoimmunity in patients with selective IgA deficiency","volume":"25","author":"Abolhassani","year":"2015","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"(suppl 1)","key":"R13-20230914","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1007\/s10875-008-9182-7","article-title":"Autoimmune manifestations in common variable immunodeficiency","volume":"28","author":"Cunningham-Rundles","year":"2008","journal-title":"J Clin Immunol"},{"key":"R14-20230914","first-page":"323","article-title":"Autoimmune phenotype in patients with common variable immunodeficiency","volume":"23","author":"Abolhassani","year":"2013","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1556\/amicr.59.2012.3.5","article-title":"Autoimmune diseases detected in children with primary immunodeficiency diseases: results from a reference centre at middle anatolia","volume":"59","author":"Patiroglu","year":"2012","journal-title":"Acta Microbiol Immunol Hung"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/CMR.00001-09","article-title":"Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections","volume":"22","author":"Fried","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00018-011-0837-9","article-title":"Inflammatory bowel disease: is it a primary immunodeficiency","volume":"69","author":"Glocker","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"R18-20230914","first-page":"480947","article-title":"Membranoproliferative glomerulonephritis and x-linked agammaglobulinemia: an uncommon association","volume":"2014","author":"Lavrador","year":"2014","journal-title":"Case Rep Pediatr"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1054\/blre.2001.0185","article-title":"Hematologic complications of primary immune deficiencies","volume":"16","author":"Cunningham-Rundles","year":"2002","journal-title":"Blood Rev"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase \u03b4 gene mutation predisposes to respiratory infection and airway damage","volume":"342","author":"Angulo","year":"2013","journal-title":"Science"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jaci.2017.03.026","article-title":"Novel PIK3CD mutations affecting N-terminal residues of p110\u03b4 cause activated PI3K\u03b4 syndrome (APDS) in humans","volume":"140","author":"Takeda","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/ACI.0000000000000217","article-title":"Gain-of-function mutations and immunodeficiency: at a loss for proper tuning of lymphocyte signaling","volume":"15","author":"Arjunaraja","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.4049\/jimmunol.1101602","article-title":"Enhanced phosphoinositide 3-kinase \u03b4 activity is a frequent event in systemic lupus erythematosus that confers resistance to activation-induced T cell death","volume":"187","author":"Su\u00e1rez-Fueyo","year":"2011","journal-title":"J Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201905030-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:27:11Z","timestamp":1694726831000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201905030-00016"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":23,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000015329","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}